Unternehmensportrait
Werewolf Therapeutics is a highly innovative company striving to redefine the cancer treatment landscape with potential best-in-class therapies. It develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. They invented proprietary PREDATOR™ protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients.
Vorstand & Aufsichtsrat
Vorstandsvorsitzender |
Dan Hicklin |
Vorstand |
Tim Trost, Randi Isaacs, Chulani Karunatilake, Ellen Lubman, Cynthia Seidel-Dugan |
Aufsichtsrat |
Luke Evnin, Michael Atkins, Meeta Chatterjee, Derek DiRocco, Dan Hicklin, Alon Lazarus, Briggs W. Morrison, Mike Sherman |
Unternehmensinformationen
Name: |
Werewolf Therapeutics Inc |
Adresse: |
200 Talcott Avenue, 2nd Floor,Watertown, MA 02472 |
Telefon: |
+1 617-952-0555 |
Fax: |
- |
E-Mail: |
info@werewolftx.com
|
Internet: |
https://werewolftx.com/ |
Industrie: |
Biotechnologie |
Sektor: |
Biotechnologie |
Sub-Sektor: |
- |
Ende des Finanzjahres: |
31.12 |
Streubesitz: |
- |
IPO Datum: |
29.04.2021 |
Investor Relations
Name: |
Josh Rappaport |
IR Telefon: |
+1 212-362-1200 |
IR Fax: |
- |
IR E-Mail: |
IR@werewolftx.com
|